Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Breast Cancer Study of Epirubicin + CMF v Classical CMF Adjuvant Therapy

NCT00003577 is registered in ClinicalTrials.gov with University Hospital Birmingham as lead sponsor.

NCT NCT00003577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Breast Cancer Study of Epirubicin + CMF v Classical CMF Adjuvant Therapy
Lead sponsor
University Hospital Birmingham
Phase
Phase 3
Overall status
Completed
Start date
March 31, 1996
Completion date
September 30, 2008
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer